- Cambrex has opened a new cGMP facility in Durham, North Carolina, expanding its stability storage capacity.
- The facility supports temperature-controlled storage services, stability testing, and other analytical services for the pharmaceutical, medical device, and life sciences sectors.
Cambrex, a global contract development and manufacturing organisation (CDMO), has announced the opening of a new cGMP stability storage facility in Durham, North Carolina. The facility, operated by its subsidiary Q1 Scientific, expands the company’s capability to provide temperature-controlled storage services to the pharmaceutical, medical device, and life sciences sectors across North America.
Strategically located in the Research Triangle Park region, the new site includes seven ICH stability chambers, designed to accommodate a range of storage conditions, including ultra-low temperatures (-70°C/-80°C) and more standard storage settings such as 25°C/60%RH and 40°C/75%RH. The location allows for same-day and next-day delivery services throughout the United States, enhancing the company’s service offerings to its clients.
“After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific,” commented Tom Loewald, CEO of Cambrex.
This new facility complements Q1 Scientific’s existing operations in Ireland and Belgium and is co-located with Cambrex’s existing analytical services site in Durham. According to Stephen Delaney, Managing Director of Q1 Scientific, the facility offers more than just storage services. “With the capabilities and expertise co-located in Durham, we can now deliver services beyond stability storage, such as stability testing and other analytical services for clinical and commercial products,” he noted.
Overview of outsourcing trends 
